Timmy Jernigan

3-4 Defensive End

  • 2020 Salary Cap Charge: $0
  • % of 2020 Team Cap: 0.00%
  • 2020 Cash Payout: $0
  • % of 2020 Team Cash Spending: 0.00%
  • 2020 Cash to Cap Ratio: 0
  • Total Contract Value: $0
  • Annual Contract Value: $0
  • Position Ranking: 90/90 at 34DE
  • Fully Guaranteed Money: $0
  • Age: 27
  • Height: 6' 2"
  • Weight: 299
  • College: Florida State
  • Accrued Seasons: 6
  • Entry: 2014 Draft, Round 2, #48 overall (Ravens)
  • Year Signed: 2020 (UFA)
  • Free Agency: 2021 (UFA)
  • 2019 OTC Valuation: $753,000

Contract Notes

Timmy Jernigan signed a one year contract with the Philadelphia Eagles on April 26, 2019 worth a base value of $2 million and up to $3 million with incentives.  Jernigan received a $1 million guarantee consisting of a $250,000 signing bonus and $750,000 salary guarantee.  Jernigan can earn up to $500,000 ($31,250 per game active) in roster bonuses, a $250,000 workout bonus, and up to $1 million in playing time incentives.

Current Contract

(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryCap
Number
Cap %
Dead Money & Cap Savings
202028$0$00.0%
Total$0$0
Embed This Contract
<iframe src="https://overthecap.com/contract-embed/2987/" width="600" height="214" frameborder="0" scrolling="no"></iframe>
Career Earnings: $19,195,402
Career APY: $3,199,234
Potential Earnings: $19,195,402
Total Guarantees: $18,732,477
Largest Cash Payment: $11,017,669 (2017)
Largest Cap Hit: $5,000,000 (2018)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
EaglesDraftedRenegotiated20144$4,382,902$1,095,726$2,126,787$00.0%$0
RavensDraftedTraded20144$4,382,902$1,095,726$2,126,787$3,365,23376.8%$1,121,744
EaglesExtensionExpired20174$48,000,000$12,000,000$13,478,903$14,017,66929.2%$7,008,835
EaglesSFAExpired20191$2,000,000$2,000,000$1,000,000$1,812,50090.6%$1,812,500
TexansUFAActive20201$0$0$0$00.0%$0
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money
Eagles3$15,830,169$5,276,723$10,019,5600.0%$6,000,0000.0%
Ravens3$3,365,233$1,121,744$2,988,3420.0%$376,8910.0%
Texans0$0$0$00.0%$00.0%

Salary Cap History

YearTeamBase SalaryProrated BonusPer Game Roster BonusWorkout BonusGuaranteed SalaryCap
Number
Cap %Cash Paid
2014Ravens$420,000$376,891$0$0$0$796,8910.6%$1,927,564
2015Ravens$619,223$376,891$0$0$619,223$996,1140.7%$619,223
2016Ravens$818,446$376,891$0$0$0$1,195,3370.8%$818,446
2017Eagles$1,017,669$2,376,891$0$0$478,903$3,394,5602.0%$11,017,669
2018Eagles$3,000,000$2,000,000$0$0$3,000,000$5,000,0002.8%$3,000,000
2019Eagles$1,000,000$250,000$500,000$250,000$750,000$1,625,0000.9%$1,812,500
2020Texans$0$0$0$0$0$00.0%$0
Total$6,875,338$5,757,564$500,000$250,000$4,848,126$13,007,902$19,195,402
Dead Money History
TeamYearCap ChargeCash Paid
Ravens2017$376,891$0
Eagles2019$6,000,000$0
Total$6,376,891$0

Statistics

YearGames PlayedGames MissedSnapsTacklesNegative PlaysInterceptionsFumblesTD
InjuredHealthyDefenseSpecialSoloAssistSacksYardsTFLQB HitsPass Def.INTYardsForcedRec.Yards
2014124028.1%0.0%11124273100000000
2015151050.2%0.4%1819436.54140000000
2016160060.3%0.0%16155369113100110
2017150147.7%12.0%16132.517980000000
201831204.4%0.2%2000110000000
2019106027.1%0.2%73220330000000

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Regular$750,000$0
Injury Adjusted$1,720,227$0
test
OTC Valuation $2.8M $5.7M $8.5M $11.4M $14.2M APY $3.8M $7.5M $11.3M $15.0M $18.8M $4,373,000 $5,933,333

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.